Many men do not understand what their prostate does and how it can impact their lives. The prostate is a small gland that is about the size and shape of a walnut that is located below the neck of the bladder. The urethra runs through the center of your prostate, from the bladder through the penis, letting urine flow out of the body.
Your prostate is a male reproductive organ. The main function of your prostate is to produce prostatic fluid. The prostatic fluid is an alkaline fluid secreted by the prostate gland during ejaculation that forms part of the semen.
Your prostate can become larger as you age, and usually begins to grow around the age of 40-50, this is a normal part of aging. Eventually, this growth can lead to Benign Prostatic Hyperplasia, better known as BPH.
Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. BPH is a very common condition that affects over 660 million aging men worldwide. Over 40% of men in their 50s and over 70% of men in their 60s have BPH. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life.
As the prostate enlarges, it presses on and blocks the urethra, causing bothersome urinary symptoms such as:2,3
If you suffer from the above symptoms, you are not alone. BPH is the leading reason men visit a urologist2.
Source Information
INFORMATION FOR PATIENTS ABOUT THE UROLIFT® SYSTEM
The UroLift System’s implants, which can be delivered during an outpatient procedure, relieve prostate obstruction without heating, cutting, destruction of, or removing prostate tissue.
The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.1 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.*2-4
Most common side effects are temporary and can include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.5 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
Treatment using the UroLift System is not appropriate if you have a prostate volume greater than 100cc, a urinary tract infection or other conditions that can be identified by your urologist.
Individual results with the UroLift System may vary.
WARNINGS:
1) THE UROLIFT SYSTEM’S IMPLANTS ARE PERMANENT (THAT IS TO SAY: ONCE IMPLANTED, THEY CANNOT BE COMPLETELY REMOVED).
2) THE UROLIFT SYSTEM’S IMPLANTS CONTAIN STAINLESS STEEL AND NITINOL, AN ALLOY OF NICKEL AND TITANIUM. INDIVIDUALS WHO ARE ALLERGIC TO THESE METALS MAY SUFFER AN ALLERGIC REACTION TO THE IMPLANT. PRIOR TO HAVING A UROLIFT SYSTEM PROCEDURE, YOU SHOULD DISCUSS ANY ALLERGY/HYPERSENSITIVITY TO THESE MATERIALS WITH YOUR UROLOGIST.
3) THE ABOVEMENTIONED INFORMATION IS NOT INTENDED TO PROVIDE MEDICAL ADVICE TO PATIENTS OR TO REPLACE THEIR DOCTORS' EXPERT OPINION AND CARE.
4) ONLY A DOCTOR CAN DIAGNOSE WHETHER HIS/HER PATIENT HAS BPH, ASSESS HIS INDIVIDUAL CONDITION AND DEFINE WHETHER UROLIFT SYSTEM IS THE ADEQUATE TREATMENT OR NOT.
5) TALK TO YOUR UROLOGIST FOR MORE INFORMATION ABOUT THE UROLIFT SYSTEM AND TO DETERMINE IF IT IS THE RIGHT TREATMENT FOR YOU.
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.
Teleflex, BPH Relief In Sight and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. ©2023 Teleflex Incorporated. All rights reserved. Revised: 02/2023. MC-008657 LA EN
Teleflex Medical Brasil Ltda
Rua Alexandre Dumas, 2100/132 - Chacara Santo Antonio
São Paulo/SP - CEP 04717-913